Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MAB1340 Anti-Collagen Type I Antibody, clone C11

MAB1340
100 µg  
Purchase on Sigma-Aldrich

Special Offers

Overview

Replacement Information

Key Spec Table

Species ReactivityKey ApplicationsHostFormatAntibody Type
HELISA, IHCMAscitesMonoclonal Antibody
Description
Catalogue NumberMAB1340
Brand Family Chemicon®
Trade Name
  • Chemicon
DescriptionAnti-Collagen Type I Antibody, clone C11
References
Product Information
FormatAscites
HS Code3002 15 90
Control
  • Mouse skin and mouse liver tissues
PresentationImmunoglobulin Purified from ascites by ammonium sulfate precipitation and chromatography on DEAE-cellulose. . Lyophilized, reconstitute with 1 mL of distilled water.
Quality LevelMQ100
Applications
ApplicationDetect Collagen Type I using this Anti-Collagen Type I Antibody, clone C11 validated for use in ELISA, IH.
Key Applications
  • ELISA
  • Immunohistochemistry
Application NotesImmunohistochemical staining of 10 μm thick cryostat sections fixed with acetone or ethanol. Staining is similar to that for polyclonal antibodies to interstitial collagen I. Suggested working concentration 10-20 μg/mL. Formaldehyde fixation is not recommended. Does not work with Western blots. Not suitable for use on paraffin embedded sections.

ELISA: Apparent binding constant from titration curves is approximately 0.1nM. Antibody suitable for use in sandwich ELISA for specific determination of collagen I, employed as either a capture antibody or as a second, detecting antibody.

Optimal working dilutions must be determined by the end user.
Biological Information
CloneC11
ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
HostMouse
SpecificityRecognizes both native and heat denatured human collagen type I. No cross reactivity with albumin fractions of human serum or albumins of other animal species. Less than 5% binding to collagens II and II in ELISA, RIA or immunoblotting.
IsotypeIgG
Species Reactivity
  • Human
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Entrez Gene SummaryThis gene encodes the pro-alpha1 chains of type I collagen whose triple helix comprises two alpha1 chains and one alpha2 chain. Type I is a fibril-forming collagen found in most connective tissues and is abundant in bone, cornea, dermis and tendon. Mutations in this gene are associated with osteogenesis imperfecta types I-IV, Ehlers-Danlos syndrome type VIIA, Ehlers-Danlos syndrome Classical type, Caffey Disease and idiopathic osteoporosis. Reciprocal translocations between chromosomes 17 and 22, where this gene and the gene for platelet-derived growth factor beta are located, are associated with a particular type of skin tumor called dermatofibrosarcoma protuberans, resulting from unregulated expression of the growth factor. Two transcripts, resulting from the use of alternate polyadenylation signals, have been identified for this gene. [provided by R. Dalgleish]
Gene Symbol
  • COL1A1
  • OI4
Purification MethodPurified
UniProt Number
UniProt SummaryFUNCTION: SwissProt: P02452 # Type I collagen is a member of group I collagen (fibrillar forming collagen).
SIZE: 1464 amino acids; 138911 Da
SUBUNIT: Trimers of one alpha 2(I) and two alpha 1(I) chains. Interacts with MRC2 (By similarity).
SUBCELLULAR LOCATION: Secreted, extracellular space, extracellular matrix (By similarity).
TISSUE SPECIFICITY: Forms the fibrils of tendon, ligaments and bones. In bones the fibrils are mineralized with calcium hydroxyapatite.
PTM: Proline residues at the third position of the tripeptide repeating unit (G-X-Y) are hydroxylated in some or all of the chains. & O-linked glycan consists of a Glc-Gal disaccharide bound to the oxygen atom of a post-translationally added hydroxyl group.
DISEASE: SwissProt: P02452 # Defects in COL1A1 are the cause of Caffey disease [MIM:114000]; also known as infantile cortical hyperostosis. Caffey disease is characterized by an infantile episode of massive subperiosteal new bone formation that typically involves the diaphyses of the long bones, mandible, and clavicles. The involved bones may also appear inflamed, with painful swelling and systemic fever often accompanying the illness. The bone changes usually begin before 5 months of age and resolve before 2 years of age. & Defects in COL1A1 are a cause of Ehlers-Danlos syndrome type I (EDS-I) [MIM:130000]; also known as Ehlers-Danlos syndrome gravis. Ehlers-Danlos syndrome is a genetically and phenotypically heterogeneous connective-tissue disorder characterized by loose- jointedness and fragile, velvety, stretchable, bruisable skin that heals with peculiar 'cigarette-paper' scars. EDS-I is an autosomal dominant trait. & Defects in COL1A1 are a cause of autosomal dominant Ehlers-Danlos syndrome type VII (EDS-VII) [MIM:130060]; which includes also Ehlers-Danlos syndrome type VII-A1. EDS-VII is characterized by arthrochalasis multiplex congenita, skin hyperextensibility and bruisability. & Defects in COL1A1 are a cause of osteogenesis imperfecta type I (OI-I) [MIM:166200]. OI-I is a dominantly inherited serious newborn disease characterized by bone fragility, normal stature, little or no deformity, blue sclerae and hearing loss in 50% of families. Dentinogenesis imperfecta is rare and may distinguish a subset of OI type I (formation of dentine). & Defects in COL1A1 are a cause of osteogenesis imperfecta type II (OI-II) [MIM:166210]; also known as osteogenesis imperfecta congenita. OI-II is lethal in the perinatal period and is charaterized by calvarial mineralization, beaded ribs, compressed femurs, marked long bone deformity and platyspondyly (congenital flattening of the vertebral bodies). & Defects in COL1A1 are a cause of osteogenesis imperfecta type III (OI-III) [MIM:259420]; also called progressively deforming osteogenesis imperfecta with normal sclerae. OI-III is characterized by progressively deforming bones, usually with moderate deformity at birth, sclerae is variable in color, dentinogenesis imperfecta and hearing loss are common. The stature is very short. & Defects in COL1A1 are a cause of osteogenesis imperfecta type IV (OI-IV) [MIM:166220]. OI-IV is charaterized by normal sclerae, moderate to mild deformity and variable short stature. Dentinogenesis imperfecta is common and hearing loss occurs in some patients. & Genetic variations in COL1A1 are associated with susceptibility to involutional osteoporosis [MIM:166710]; also known as senile osteoporosis or postmenopausal osteoporosis. Osteoporosis is characterized by reduced bone mineral density, disrutption of bone microarchitecture, and the alteration of the amount and variety of non-collagenous proteins in bone. Osteoporotic bones are more at risk of fracture. & A chromosomal aberration involving COL1A1 is a cause of dermatofibrosarcoma protuberans (DFSP) [MIM:607907]. Translocation t(17;22)(q22;q13) with PDGF. DFSP is an uncommon, locally aggressive, but rarely metastasizing tumor of the deep dermis and subcutaneous tissue. It typically occurs during early or middle adult life and is most frequently located on the trunk and proximal extremities.
SIMILARITY: SwissProt: P02452 ## Belongs to the fibrillar collagen family. & Contains 1 VWFC domain.
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsMaintain for 2 years at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Packaging Information
Material Size100 µg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Catalogue Number GTIN
MAB1340 04053252358852

Documentation

Anti-Collagen Type I Antibody, clone C11 SDS

Title

Safety Data Sheet (SDS) 

Anti-Collagen Type I Antibody, clone C11 Certificates of Analysis

TitleLot Number
MOUSE ANTI-HUMAN COLLAGEN TYPE I MONOCLONAL ANTIBODY - 2107200 2107200
MOUSE ANTI-HUMAN COLLAGEN TYPE I MONOCLONAL ANTIBODY - 2118008 2118008
MOUSE ANTI-HUMAN COLLAGEN TYPE I MONOCLONAL ANTIBODY - 2446681 2446681
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 2527450 2527450
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 3288529 3288529
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 3305201 3305201
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 3598004 3598004
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 3873529 3873529
MOUSE ANTI-HUMAN COLLAGEN TYPE I - 4041718 4041718
MOUSE ANTI-HUMAN COLLAGEN TYPE I -2547174 2547174

References

Reference overviewPub Med ID
Mesenchymal stem cells in rabbit meniscus and bone marrow exhibit a similar feature but a heterogeneous multi-differentiation potential: superiority of meniscus as a cell source for meniscus repair.
Ding, Z; Huang, H
BMC musculoskeletal disorders  16  65  2015

Show Abstract
25887689 25887689
Human tendon stem cells better maintain their stemness in hypoxic culture conditions.
Zhang, J; Wang, JH
PloS one  8  e61424  2013

Show Abstract
23613849 23613849
Characterization of the urethral plate and the underlying tissue defined by expression of collagen subtypes and microarchitecture in hypospadias.
Hayashi Y, Mizuno K, Kojima Y, Moritoki Y, Nishio H, Kato T, Kurokawa S, Kamisawa H, Kohri K
International journal of urology : official journal of the Japanese Urological Association  2011

Show Abstract
21332824 21332824
Autologous chondrocyte implantation in the knee joint: open compared with arthroscopic technique. Comparison at a minimum follow-up of five years.
Alberto Ferruzzi, Roberto Buda, Cesare Faldini, Francesca Vannini, Francesco Di Caprio, Deianira Luciani, Sandro Giannini
The Journal of bone and joint surgery. American volume  90 Suppl 4  90-101  2008

18984722 18984722
Lipoprotein lipase in the arterial wall: linking LDL to the arterial extracellular matrix and much more.
Markku O Pentikäinen, Riina Oksjoki, Katariina Oörni, Petri T Kovanen
Arteriosclerosis, thrombosis, and vascular biology  22  211-7  2002

Show Abstract
11834518 11834518
Imaging cells and extracellular matrix in vivo by using second-harmonic generation and two-photon excited fluorescence.
Zoumi, A; Yeh, A; Tromberg, BJ
Proceedings of the National Academy of Sciences of the United States of America  99  11014-9  2002

Show Abstract
12177437 12177437
Lipoprotein lipase (LPL) strongly links native and oxidized low density lipoprotein particles to decorin-coated collagen. Roles for both dimeric and monomeric forms of LPL.
M O Pentikäinen, K Oörni, P T Kovanen
The Journal of biological chemistry  275  5694-701  2000

Show Abstract
10681554 10681554
Regulated production of type I collagen and inflammatory cytokines by peripheral blood fibrocytes.
J Chesney, C Metz, A B Stavitsky, M Bacher, R Bucala
Journal of immunology (Baltimore, Md. : 1950)  160  419-25  1998

Show Abstract
9551999 9551999
Immunohistochemical characterization of intact stromal layers in long-term cultures of human bone marrow.
Wilkins, B S and Jones, D B
Br. J. Haematol., 90: 757-66 (1995)  1995

Show Abstract
7669654 7669654
Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6/E7 genes.
B A Roecklein, B Torok-Storb
Blood  85  997-1005  1995

Show Abstract
7849321 7849321

Related Products & Applications

Related Products

Product Families

Categories

Life Science Research > Antibodies and Assays > Primary Antibodies